1. Home
  2. MIND vs ALGS Comparison

MIND vs ALGS Comparison

Compare MIND & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MIND Technology Inc. (DE)

MIND

MIND Technology Inc. (DE)

HOLD

Current Price

$4.08

Market Cap

41.2M

Sector

Industrials

ML Signal

HOLD

Logo Aligos Therapeutics Inc.

ALGS

Aligos Therapeutics Inc.

HOLD

Current Price

$4.80

Market Cap

34.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIND
ALGS
Founded
1987
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.2M
34.6M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
MIND
ALGS
Price
$4.08
$4.80
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $52.38
AVG Volume (30 Days)
★ 55.2K
35.4K
Earning Date
12-08-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
29.77
★ 88.30
EPS
★ N/A
N/A
Revenue
★ $42,675,000.00
$2,186,000.00
Revenue This Year
N/A
$1,562.10
Revenue Next Year
$73.65
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.63
$3.98
52 Week High
$14.50
$13.69

Technical Indicators

Market Signals
Indicator
MIND
ALGS
Relative Strength Index (RSI) 40.10 36.83
Support Level $3.63 N/A
Resistance Level $4.78 $6.91
Average True Range (ATR) 0.24 0.35
MACD -0.03 -0.04
Stochastic Oscillator 6.10 21.84

Price Performance

Historical Comparison
MIND
ALGS

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in single segment namely, Seamap which provides services and products, including engineering, repairs and software licensing, utilized in marine exploration, marine survey and maritime security for marine survey companies, seismic survey contractors, research institutes, non-military government organizations and operators of port facilities and other offshore installations. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.

Share on Social Networks: